Fund Holdings

Foresite Capital Management VI LLC

Filing Period:
Securities
SharesValue ($K)
Q2 2025
Q3 2025
Change
Q2 2025
Q3 2025
Weight (%)
Change
CG Oncology, Inc.(CGON)2,221,4742,221,474057,758,32489,480,97334.57%+31,722,649
RAPT Therapeutics, Inc.1,562,5001,562,500012,500,00040,296,87515.57%+27,796,875
Verastem, Inc.1,276,5202,615,120+1,338,6005,297,55823,091,5108.92%+17,793,952
Centessa Pharmaceuticals plc1,253,3791,314,019+60,64016,469,40031,864,96112.31%+15,395,561
Denali Therapeutics Inc.(DNLI)01,000,000+1,000,000014,520,0005.61%+14,520,000
Corvus Pharmaceuticals, Inc.(CRVS)1,731,2331,731,23306,924,93212,759,1874.93%+5,834,255
ALUMIS INC.4,247,6704,247,670012,743,01016,948,2036.55%+4,205,193
Kymera Therapeutics, Inc.(KYMR)146,332146,33206,385,9288,282,3913.20%+1,896,463
CASI Pharmaceuticals, Inc.787,121979,956+192,835928,8031,626,7270.63%+697,924
Avidity Biosciences, Inc.40,00040,00001,136,0001,742,8000.67%+606,800
Viridian Therapeutics, Inc(VRDN)1,9740-1,97427,5970-27,597
Hinge Health, Inc.(HNGE)135,000135,00006,986,2506,625,8002.56%-360,450
Spyre Therapeutics Inc(SYRE)70,0000-70,0001,047,9000-1,047,900
Akero Therapeutics, Inc.244,900244,900013,067,86411,627,8524.49%-1,440,012
Ideaya Biosciences Inc(IDYA)144,4680-144,4683,036,7170-3,036,717
Allogene Therapeutics Inc2,875,3570-2,875,3573,249,1530-3,249,153
Structure Therapeutics Inc210,0000-210,0004,355,4000-4,355,400
Cullinan Therapeutics Inc(CGEM)594,0250-594,0254,473,0080-4,473,008
Xenon Pharmaceuticals Inc(XENE)160,0000-160,0005,008,0000-5,008,000
Edgewise Therapeutics Inc(EWTX)585,0000-585,0007,669,3500-7,669,350
Bicara Therapeutics Inc949,2600-949,2608,818,6250-8,818,625
Page 1 of 1